Ester Falconer - Sep 1, 2021 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role
Chief Technology Officer
Signature
/s/ Tryn Stimart, attorney-in-fact
Stock symbol
ABCL
Transactions as of
Sep 1, 2021
Transactions value $
$14,778,750
Form type
4
Date filed
9/3/2021, 04:18 PM
Previous filing
Jun 10, 2021
Next filing
Sep 24, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABCL Common Shares Options Exercise $14.8M +875K $16.89 875K Sep 1, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABCL Share option (right to buy) Options Exercise $0 -875K -50% $0.00 875K Sep 1, 2021 Common Shares 875K $0.31 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to such option vest and become exercisable annually in substantially equal installments over a three-year period, with the first tranche vested on January 1, 2020, subject to the Reporting Person's continuous service to the Issuer on each such date